

Hutchmed China to trade in Shanghai and Shenzhen through link scheme


Hutchmed launches trial into drug combination to treat breast cancer


(Sharecast News) - Commercial-stage biotechnology company Hutchmed China announced a collaboration to research, develop, manufacture and commercialise...


Hutchmed to partner with Epizyme on tumour-targetting treatment


Hutchmed research costs deepen loss; expects US launches in 2022, 2023


IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial


AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%


UK earnings, trading statements calendar - next 7 days